arginyl-glycyl-aspartic acid and Ductal Carcinoma

arginyl-glycyl-aspartic acid has been researched along with Ductal Carcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Duffin, TD; Griggs, DW; Keene, JL; Nickols, MA; Ruminski, PG; Schroeter, S; Settle, SL; Shannon, KE; Westlin, M	1

Other Studies

1 other study(ies) available for arginyl-glycyl-aspartic acid and Ductal Carcinoma

Article	Year
Anti-metastatic properties of RGD-peptidomimetic agents S137 and S247. Clinical & experimental metastasis, 2004, Volume: 21, Issue:2 Topics: Administration, Oral; Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal; Cell Division; Cell Line, Tumor; Cell Movement; Colonic Neoplasms; Dipeptides; Drug Administration Schedule; Endothelial Cells; Endothelium, Vascular; Female; Humans; Infusion Pumps, Implantable; Integrin alphaVbeta3; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, SCID; Neoplasm Proteins; Neoplastic Cells, Circulating; Oligopeptides; Organic Chemicals; Pyrimidines; Xenograft Model Antitumor Assays	2004

Article

Year

Anti-metastatic properties of RGD-peptidomimetic agents S137 and S247.

Clinical & experimental metastasis, 2004, Volume: 21, Issue:2

Topics: Administration, Oral; Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal; Cell Division; Cell Line, Tumor; Cell Movement; Colonic Neoplasms; Dipeptides; Drug Administration Schedule; Endothelial Cells; Endothelium, Vascular; Female; Humans; Infusion Pumps, Implantable; Integrin alphaVbeta3; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, SCID; Neoplasm Proteins; Neoplastic Cells, Circulating; Oligopeptides; Organic Chemicals; Pyrimidines; Xenograft Model Antitumor Assays

2004